该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-02-08 AccNo: 0001437749-18-001987 Size: 11 MB 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-02-08 AccNo: 0001437749-18-001981 Size: 404 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-02-08 AccNo: 0001437749-18-001987 Size: 11 MB 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-02-08 AccNo: 0001437749-18-001981 Size: 404 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 美东时间 2018-02-08 盘前 披露财报,预期EPS 1.1 网页链接
$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-05 AccNo: 0001258897-18-000253 Size: 52 KB 网页链接
$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-23 AccNo: 0000215457-18-002175 Size: 13 KB 网页链接
$凯姆布雷克斯(CBM)$ CORRESP [Cover] - Correspondence Filed: 2017-11-27 AccNo: 0001437749-17-019803 Size: 22 KB 网页链接
$凯姆布雷克斯(CBM)$ UPLOAD [Cover] - SEC-generated letter Filed: 2018-01-05 AccNo: 0000000000-18-000473 Size: 40 KB 网页链接
$凯姆布雷克斯(CBM)$ CORRESP [Cover] - Correspondence Filed: 2017-11-27 AccNo: 0001437749-17-019803 Size: 22 KB 网页链接